Precision Medicine

D. Geoffrey Vince, a biomedical engineer at the health system, will lead new efforts to build out computer science and data research, with the goal of drug discovery and other clinical innovations.

The plan focuses on expanding the diversity and reach of genomics in the UK as well as improving patient diagnosis, treatment and sickness prevention.

Assaf Halevy, CEO and founder of 2bPrecise, says genomic information can be injected into the workflow to manage the treatment of the patient.

The healthcare landscape has transformed drastically over the years and we have found ourselves in a situation where both patients and consumers alike are becoming more engaged and involved in their own health.

The provider organization is improving personalized medication management and health outcomes for senior patients on multiple medications.

Developed by researchers at Boston Children’s Hospital, Harvard, Northeastern, Oxford and other academic organizations, the new dataset offers researchers access to more than 5 million anonymized cases from more than 100 countries.

ARIA will be used to quickly identify and fund transformational science and technology.

The research team noted that lung tissue gets stiffer as a person gets older, showing different patterns of gene expression than in younger people.

AdventHealth, Advocate Aurora, Northwell, Novant, Providence and Tenet are just some of the major providers collaborating on the new data platform, whose goal is to "improve health equity and advance personalized medicine," according to its CEO.

Vaccines by six developers – Sinopharm, Sinovac, Pfizer-BioNTech, Moderna, Oxford-AstraZeneca, and Sputnik V (Gamaleya Research Institute) – are the ones doing the rounds in the region. Here’s what’s known about them.